Chengdu Kanghong Pharmaceutical Group Co., Ltd

SZSE:002773.SZ

15.14 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 1,031.124865.811421.081-269.853718.19694.944644.199500.12396.986276.465319.13205.778167.667108.50782.447
Depreciation & Amortization 225.703158.272149.382118.593.02874.00465.21663.45864.84866.74457.52349.37330.70126.95622.382
Deferred Income Tax 062.424-115.954-361.346-18.263-18.02721.712-19.752-13.539000000
Stock Based Compensation 07.7884.54900.791-5.95835.50641.8470000000
Change In Working Capital -67.014-76.627-270.473-276.43216.078-392.3747.899245.58623.515-43.7297.601-17.115-59.968-17-4.214
Accounts Receivables -5.8216.124151.98396.349-16.51-264.649-105.90515.5579.372-48.0745.437-1.774000
Inventory -65.013-38.464-57.03523.016-9.703-79.716-27.556-33.891-8.703-24.3485.156-17.144-23.793-10.07-8.107
Accounts Payables -61.363-116.711-249.468-34.4560.554-29.982119.648283.67236.385000000
Other Working Capital 65.18262.424-115.954-361.346-18.263-312.65835.454279.47732.218-19.382.4450.03-36.175-6.933.893
Other Non Cash Items 28.597-92.514305.53701.1012.321-25.68949.54837.182-3.378-8.105-50.93943.80330.45918.3327.808
Operating Cash Flow 1,218.411925.153494.114273.315812.146350.884766.862846.345481.972291.376333.315281.839168.858136.794108.423
Investing Activities:
Investments In Property Plant And Equipment -138.874-355.207-569.418-617.066-962.876-458.45-312.882-170.226-115.828-90.269-77.157-129.507-157.254-131.762-158.267
Acquisitions Net 9.61720.7540.0810.0370-115.040.0520.2680.1260.3860.0080.2520.0650.0550.164
Purchases Of Investments -4,576.54-5,692.8-4,317.555-5,964.33-2,006.976-2,850-3,162.75-2,927.689-3,122.25-2,254.105-738.3-249.4-144.8-76.151-463.635
Sales Maturities Of Investments 4,676.545,832.2054,093.2465,998.572,187.4992,657.3443,453.3582,820.5772,981.22,286.82816.831275.188140.07931.987411.269
Other Investing Activites 35.873-20.505-9.49-1.176-11.59810.50798.0426.908-5.01322.7461.86720.67713.411.45840.301
Investing Cash Flow 6.616-215.553-803.136-583.965-793.952-755.63975.818-250.162-261.766-34.4233.248-82.79-148.51-164.413-170.168
Financing Activities:
Debt Repayment 0-2.6-2.13300000-5-2-35-15-371.306-20
Common Stock Issued 0001,606.49200000000000
Common Stock Repurchased 000-0.346-40.516-16.782-21.80500000000
Dividends Paid -137.92-91.946-91.946-244.582-188.14-188.549-100.757-89.12-60.127-54.306-37.372-39.655-140.789-24.97-16.029
Other Financing Activities 7.42220.69515.241,601.776-1.596-16.782-21.805187.07586.016-1.093-1.206-0.77258.7500
Financing Cash Flow -130.498-73.851-78.8391,357.173-230.252-205.331-122.56397.95520.889-57.399-73.578-55.425114.96146.336-36.029
Other Information:
Effect Of Forex Changes On Cash -0.2120.987-0.869-2.5992.6741.631-4.7794.3341.103-0.062-0.764000-0
Net Change In Cash 1,094.318636.736-388.731,043.925-209.384-608.454715.339698.467742.197199.491262.221143.624135.30918.717-97.775
Cash At End Of Period 4,669.9943,575.6762,938.943,327.672,283.7452,493.1293,101.5832,386.2441,687.777945.58746.089483.868340.244204.936186.218